Ind-Swift Laboratories Q3 Results
- BSE: 532305
- NSE: INDSWFTLAB
- ISIN: INE915B01019
- Sector: Major Drugs
BSE
99.85
-2.00 (-1.96%)
-2.00 (-1.96%)Volume4.51 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
98.63-2.02 (-2.01%)
-2.02 (-2.01%)Volume37.50 K
Updated: Mon 25 Nov, 2024 | 15:15:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ind-Swift Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 287.51 | 289.71 | -% | 312.69 | -% |
| Selling/ General/ Admin Expenses Total | 37.08 | 37.46 | -% | 33.22 | -% |
| Depreciation/ Amortization | 13.56 | 13.19 | -% | 15.39 | -% |
| Other Operating Expenses Total | 43.31 | 42.11 | -% | 43.11 | -% |
| Total Operating Expense | 249.38 | 237.20 | -% | 274.31 | -% |
| Operating Income | 38.13 | 52.51 | -% | 38.37 | -% |
| Net Income Before Taxes | 24.19 | 38.77 | -% | 24.35 | -% |
| Net Income | 19.42 | 31.66 | -% | 27.50 | -% |
| Diluted Normalized EPS | 3.29 | 5.36 | -% | 4.65 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST